However, there are reports that, unlike its low dose, high dose of methylphenidate fails to offer the same therapeutic effects on hyperactivity in SHR rats [41, 61]
GLP-1 receptor agonists act on central appetite pathways in addition to improving glycemic control
Three key findings result from our study: (1) pwIIH treated with GLP-1-RAs lose significantly more weight than pwIIH electing for UCWM only, (2) treatment with GLP-1-RAs is associated with favorable headache outcomes, and (3) treatment with GLP-1-RAs is not associated with any severe adverse events in IIH, and thus presents a safe treatment option for weight management in pwIIH
Sattar N, Lee M, Kristensen SL et al (2021) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Alternatives for Pain Relief If you find that aspirin is not the best fit while on your weight loss journey, there may be other options
Research done as part of the drug's approval process for treating type 2 diabetes found people lost as much as 21 pounds over 10 months